Naropin (ropivacaine hydrochloride Injection, USP), 0.5%, 100 mg per 20 mL (5 mg per mL), Twenty-five, 20 mL Single-Dose Vials, Rx only, Fresenius Kabi, Lake Zurich, IL 60047 NDC Tray: 63323-286-23; N Recall
Recall Date
Jul 29, 2026
Company
Fresenius Kabi USA, LLC
Source
FDA
Units
92,600 vials
Reason: Presence of Particulate Matter: Hair was found in products
Official FDA recall noticeInformation is from official FDA notices. Do not stop taking any medication without consulting your doctor or pharmacist first — the risks of stopping may be greater than the risk from the recalled product.
Description
Presence of Particulate Matter: Hair was found in products
Reason for Recall
Presence of Particulate Matter: Hair was found in products
What Should I Do?
Quantity: 92,600 vials
5-step guide to help you action required this recalled product. Click Start Remediation to track your progress.
+2 more steps…
Last updated August 4, 2026
Injured by a recalled product?
Our legal partners offer free consultations for recall victims.
Stay Informed
Weekly recall digest — free, no spam.